Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-randomised, Open-label, Uncontrolled, Multi-centre, Phase IIIb Study Evaluating the Safety and Efficacy of Fluocinolone Acetonide 190 Micrograms Intravitreal Implant in Paediatric Subjects From 6 Years to Less Than 18 Years With Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye

NCT06539481 is registered in ClinicalTrials.gov with Alimera Sciences as lead sponsor.

NCT NCT06539481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06539481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-randomised, Open-label, Uncontrolled, Multi-centre, Phase IIIb Study Evaluating the Safety and Efficacy of Fluocinolone Acetonide 190 Micrograms Intravitreal Implant in Paediatric Subjects From 6 Years to Less Than 18 Years With Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Lead sponsor
Alimera Sciences
Phase
Phase 4
Overall status
Recruiting
Start date
August 31, 2024
Completion date
October 31, 2028
Enrollment
25 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

non-infectious uveitis affecting the posterior segment of the eye